- Home
- MURA vs EDRY Comparison
MURA vs EDRY Comparison
Compare MURA & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- EDRY
- Stock Information
- Founded
- MURA 2013
- EDRY 2018
- Country
- MURA Ireland
- EDRY Greece
- Employees
- MURA N/A
- EDRY N/A
- Industry
- MURA
- EDRY Marine Transportation
- Sector
- MURA
- EDRY Consumer Discretionary
- Exchange
- MURA Nasdaq
- EDRY Nasdaq
- Market Cap
- MURA 62.2M
- EDRY 57.9M
- IPO Year
- MURA N/A
- EDRY N/A
- Fundamental
- Price
- MURA $3.49
- EDRY $15.00
- Analyst Decision
- MURA Strong Buy
- EDRY Strong Buy
- Analyst Count
- MURA 4
- EDRY 1
- Target Price
- MURA $16.00
- EDRY $30.00
- AVG Volume (30 Days)
- MURA 50.8K
- EDRY 6.5K
- Earning Date
- MURA 11-13-2024
- EDRY 11-22-2024
- Dividend Yield
- MURA N/A
- EDRY N/A
- EPS Growth
- MURA N/A
- EDRY N/A
- EPS
- MURA N/A
- EDRY N/A
- Revenue
- MURA N/A
- EDRY $57,770,014.00
- Revenue This Year
- MURA N/A
- EDRY $59.92
- Revenue Next Year
- MURA N/A
- EDRY $14.08
- P/E Ratio
- MURA N/A
- EDRY N/A
- Revenue Growth
- MURA N/A
- EDRY 9.80
- 52 Week Low
- MURA $2.88
- EDRY $14.62
- 52 Week High
- MURA $6.25
- EDRY $24.84
- Technical
- Relative Strength Index (RSI)
- MURA 51.24
- EDRY 17.96
- Support Level
- MURA $3.31
- EDRY $15.47
- Resistance Level
- MURA $3.66
- EDRY $15.80
- Average True Range (ATR)
- MURA 0.17
- EDRY 0.70
- MACD
- MURA -0.01
- EDRY -0.20
- Stochastic Oscillator
- MURA 54.55
- EDRY 0.00
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.